Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011971
Filing Date
2021-05-17
Accepted
2021-05-17 17:25:28
Documents
43
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 330527
2 ex31.htm EX-31 17756
3 ex32.htm EX-32 6108
  Complete submission text file 0001493152-21-011971.txt   2197537

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE clcs-20210331.xml EX-101.INS 253264
5 XBRL SCHEMA FILE clcs-20210331.xsd EX-101.SCH 25938
6 XBRL CALCULATION FILE clcs-20210331_cal.xml EX-101.CAL 39836
7 XBRL DEFINITION FILE clcs-20210331_def.xml EX-101.DEF 116987
8 XBRL LABEL FILE clcs-20210331_lab.xml EX-101.LAB 227633
9 XBRL PRESENTATION FILE clcs-20210331_pre.xml EX-101.PRE 178462
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 21932557
SIC: 2834 Pharmaceutical Preparations